|
Volumn 48, Issue 11, 2001, Pages 1102-1108
|
Intraoperative single-shot "3-in-1" femoral nerve block with ropivacaine 0.25%, ropivacaine 0.5% or bupivacaine 0.25% provides comparable 48-hr analgesia after unilateral total knee replacement
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ATRACURIUM;
BUPIVACAINE;
FENTANYL;
ISOFLURANE;
MORPHINE;
NITROUS OXIDE PLUS OXYGEN;
ROPIVACAINE;
THIOPENTAL;
ADULT;
AGED;
ARTICLE;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONCENTRATION RESPONSE;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOSE RESPONSE;
DOUBLE BLIND PROCEDURE;
FEMALE;
FEMORAL NERVE;
HOSPITALIZATION;
HUMAN;
INTRAOPERATIVE PERIOD;
MALE;
MOVEMENT (PHYSIOLOGY);
NAUSEA;
OPERATION DURATION;
PAIN ASSESSMENT;
POSTOPERATIVE ANALGESIA;
PRIORITY JOURNAL;
PRURITUS;
RANDOMIZED CONTROLLED TRIAL;
RESPIRATION DEPRESSION;
REST;
SCORING SYSTEM;
SEDATION;
TOTAL KNEE REPLACEMENT;
TOURNIQUET;
VOMITING;
ADULT;
AGED;
AMIDES;
ANALGESICS, OPIOID;
ANESTHETICS, LOCAL;
ARTHROPLASTY, REPLACEMENT, KNEE;
BUPIVACAINE;
DOUBLE-BLIND METHOD;
FEMALE;
FEMORAL NERVE;
HUMANS;
LENGTH OF STAY;
MALE;
MIDDLE AGED;
MORPHINE;
NERVE BLOCK;
PAIN MEASUREMENT;
PAIN, POSTOPERATIVE;
POSTOPERATIVE NAUSEA AND VOMITING;
PROSPECTIVE STUDIES;
|
EID: 0035572102
PISSN: 0832610X
EISSN: None
Source Type: Journal
DOI: 10.1007/BF03020376 Document Type: Article |
Times cited : (66)
|
References (23)
|